Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms

British Journal of Pharmacology

Volumn 119, Issue 2, 1996, Pages 229-232

  Yu, Xian Jie ^a   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Capsaicin; Migraine; Neurogenic plasma extravasation; Neuropeptide Y (NPY); NPY receptor agonists; Pertussis toxin sensitive G protein; Substance P; Trigeminal ganglion

Indexed keywords

BOVINE SERUM ALBUMIN; CAPSAICIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR; PERTUSSIS TOXIN; PRESYNAPTIC RECEPTOR; SUBSTANCE P; BORDETELLA VIRULENCE FACTOR; DIAGNOSTIC AGENT; NEUROPEPTIDE Y (18 36); NEUROPEPTIDE Y (18-36); NEUROPEPTIDE Y RECEPTOR; PEPTIDE FRAGMENT; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DURA MATER; ELECTROSTIMULATION; EXTRAVASATION; MALE; MENINX; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; TRIGEMINUS GANGLION; ANIMAL; CLASSIFICATION; CONTRAST MEDIUM EXTRAVASATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SECOND MESSENGER; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; STIMULATION; VASCULARIZATION;

ANIMALS; CAPSAICIN; DURA MATER; ELECTRIC STIMULATION; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; IODINE RADIOISOTOPES; MALE; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; SECOND MESSENGER SYSTEMS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, BOVINE; STIMULATION, CHEMICAL; SUBSTANCE P; TRIGEMINAL GANGLION; VIRULENCE FACTORS, BORDETELLA;

EID: 0029658367     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15975.x     Document Type: Article

References (29)

1. BUZZI, M.G. & MOSKOWITZ, M.A. (1990). The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol., 99, 202-206.
2. BUZZI, M.G., MOSKOWITZ, M.A., PEROUTKA, S.J. & BYUN, B. (1991). Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br. J. Pharmacol., 103, 1421-1428.
3. COLMERS, W.F. & PITTMAN, Q.J. (1989). Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: Insensitivity to pertussis toxin treatment. Brain Res., 498, 99-104.
4. CUTRER, M.F., SCHOENFELD, D., LIMMROTH, V., PANAHIAN, N. & MOSKOWITZ, M.A. (1995). Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br. J. Pharmacol, 114, 987-992.
5. DUGGAN, A.W., HOPE, P.J. & LANG, C.W. (1991). Microinjection of neuropeptide Y into the superficial dorsal horn reduces stimulusevoked release of immunoreactive substance P in the anesthetized cat. Neuroscience, 44, 733-740.
6. DIMITRIADOU, V., BUZZI, M.G., MOSKOWITZ, M.A. & THEOHARIDES, T.C. (1991). Trigeminal sensory fibre stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience, 44, 97-112.
7. DIMITRIADOU, V., BUZZI, M.G., THEOHARIDES, T.C. & MOSKOWITZ, M.A. (1992). Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience, 48, 187-203.
8. GIULIANI, S., MAGGI, C.A. & MELI, A. (1989). Prejunctional modulatory action of neuropeptide Y on peripheral terminals of capsaicin-sensitive sensory nerves. Br. J. Pharmacol., 98, 407-412.
9. GOADSBY, P.J. & EDVINSSON, L. (1993). The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol., 33, 48-56.
10. GRUNDEMAR, L., GRUNDSTROM, N., JOHANSSON, I.G.M., ANDERSSON, R.G.G. & HÅKANSON, R. (1990). Suppression by neuropeptide Y of capsaicin-sensitive sensory nerve-mediated contraction in guinea-pig airways. Br. J. Pharmacol., 99, 473-476.
11. GRUNDEMAR, L. & HÅKANSON, R. (1994). Neuropeptide Y effector systems: perspectives for drug development. Trends Pharmacol. Sci., 15, 153-159.
12. HUA, X-Y., BOUBLIK, J.H., SPICER, M.A., RIVIER, J.E., BROWN, M.R. & YAKSH, T.L. (1991). The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J. Pharmacol. Exp. Ther., 258, 243-248.
13. A receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br. J. Pharmacol., 116, 1661-1667.
14. MANTYH, P.W , ALLEN, C.J, ROGERS, S., DEMASTER, E., GHILARDI, J.R., MOSCONI, T., KRUGER, L., MANNON, P.J., TAYLOR, I.L. & VIGNA, S.R. (1994). Some sensory neurons express neuropeptide Y receptors: Potential paracrine inhibition of primary afferent nociceptors following peripheral nerve injury. J. Neurosci., 14, 3958-3968.
15. MARKOWITZ, S., SAITO, K. & MOSKOWITZ, M.A. (1987). Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci., 7, 4129 4136.
16. MODIN, A., PERNOW, J. & LUNDBERG, J.M. (1991). Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur. J. Pharmacol., 203, 165-171.
17. MOSKOWITZ, M.A. (1984). The neurobiology of vascular head pain. Ann. Neurol., 16, 157-168.
18. MOSKOWITZ, M.A. (1992). Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci., 13, 307-311.
19. MOSKOWITZ, M.A. & WAEBER, C. (1996). Migraine enters the molecular era. Neuroscientist, 2, 191-200.
20. NARVÂEZ, J.A., AGUIRRE, I.A., VAN DER PLOEG, I. & FUXE, K. (1992). Intracerehroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y (13-36) in the awake unrestrained male rat. Neurosci. Lett., 140, 273-276.
21. 34] NPY, a selective functional postjunctional agonist at neuropeptide-Y receptors in anaesthetised rats. Neurosci. Lett., 134, 183-186.
22. SAITO, K., MARKOWITZ, S. & MOSKOWITZ, M.A. (1988). Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headaches. Ann. Neurol., 24, 732-737.
23. SARIA, A., GAMSE, R., LUNDBERG, J.M., HÖKFELT, T., THEODORSSON-NORHEIM, E., PETERMANN, J. & FISCHER, J.A. (1985). Co-existence of tachykinins and calcitonin gene-related peptide in sensory nerves in relation to neurogenic inflammation. In Tachykinin Antagonists, ed. Hâkanson, R. & Sundler, F. pp. 149-157. Amsterdam: Elsevier.
24. 2+ current and synaptic transmission in cultured rat hippocampal pyramidal neurones. J. Physiol., 435, 373-393.
25. 2+ currents and synaptic transmission in cultured rat hippocampal neurones. J. Physiol., 444, 669-686.
26. TAKAHASHI, T., ICHINOSE, M., YAMAUCHI, H., MIURA, M., NAKAJIMA, N., ISHIKAWA, J., INOUE, H., TAKISHIMA, T. & SHIRATO, K. (1993). Neuropeptide Y inhibits neurogenic inflammation in guinea-pig airways. J. Appl. Physiol., 75, 103-107.
27. WAGER-PAGE, S.A., RAIZADA, E., VEALE, W. & DAVISION, J.S. (1993). Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, Peptide YY, and pancreatic polypeptide in rats: Cholinergic mechanisms. Can. J. Physiol. Pharmacol., 71, 768-775.
28. WILEY, J.W., GROSS, R.A., LU, Y. & MACDONALD, R.L. (1990). Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurones via a pertussis toxin sensitive mechanism. J. Neurophysiol., 63, 1499-1507.
29. 2 receptor coupled to pertussis toxin-sensitive G protein. (Abstract) 7th International Headache Congress). Cephalagia, 15 (suppl 14), 103.